Lv7
5000 积分 2024-09-13 加入
Will the anti-fibrotic effects of Nerandomi-Last? FIBRONEER-IPF part 2
1个月前
已完结
Plasma proteome analysis and validation of patients with community‐acquired pneumonia: A cohort study
1个月前
已完结
RYK is a GPNMB receptor that drives MASH
2个月前
已完结
Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease
4个月前
已完结
Treatment Outcomes for Rheumatoid Arthritis-Associated Interstitial Lung Disease
4个月前
已完结
Treatment of rheumatoid arthritis-associated interstitial lung disease: An appraisal of the 2023 ACR/CHEST guideline
4个月前
已完结
Rheumatoid Arthritis-Associated Interstitial Lung Disease (RA-ILD): Update on Prevalence, Risk Factors, Pathogenesis, and Therapy
4个月前
已完结
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
6个月前
已完结
Metabolic Activation of Pirfenidone Mediated by Cytochrome P450s and Sulfotransferases
6个月前
已完结
Randomized Phase 2 Placebo-Controlled Trial of Nintedanib for the Treatment of Radiation Pneumonitis
7个月前
已完结
皖公网安备34019202002308
